Evidence map›Paper›PMID 19493315›Full record

ArticlePigment cell & melanoma research2009

Agouti protein, mahogunin, and attractin in pheomelanogenesis and melanoblast-like alteration of melanocytes: a cAMP-independent pathway.

Tokimasa Hida, Kazumasa Wakamatsu, Elena V Sviderskaya, Andrew J Donkin, Lluis Montoliu, M Lynn Lamoreux, Bin Yu, Glenn L Millhauser, Shosuke Ito, Gregory S Barsh and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Pigment cell & melanoma research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. A Dominant Mutation in GPigment cell & melanoma research · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. The Knockout of theAnimals : an open access journal from MDPI · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. [Research progress on the mechanism of wound skin dys- pigmentation after burns].Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

Tokimasa HidaDivision of Basic Medical Sciences, St. George's, University of London, Cranmer Terrace, London, UK.
Kazumasa Wakamatsu
Elena V Sviderskaya
Andrew J Donkin
Lluis Montoliu
M Lynn Lamoreux
Bin Yu
Glenn L Millhauser
Shosuke Ito
Gregory S Barsh
Kowichi Jimbow
Dorothy C Bennett
St George's, University of London · GBFujita Health University · JPSapporo Medical University · JPUniversity of California, Santa Cruz · USHoward Hughes Medical Institute · USInstituto de Salud Carlos III · ESTexas A&M University · US

Funding

Molecular Determinants of AGRP FunctionR01DK064265 · NIDDK · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI MILLHAUSER, GLENN L · 2003 to 2013
$3.0M
NIDDK NIH HHS DK064265NIDDK NIH HHS R01 DK064265Wellcome Trust 064583Wellcome Trust 078327
6 · The paper itself

Abstract

Melanocortin-1 receptor (MC1R) and its ligands, alpha-melanocyte stimulating hormone (alphaMSH) and agouti signaling protein (ASIP), regulate switching between eumelanin and pheomelanin synthesis in melanocytes. Here we investigated biological effects and signaling pathways of ASIP. Melan-a non agouti (a/a) mouse melanocytes produce mainly eumelanin, but ASIP combined with phenylthiourea and extra cysteine could induce over 200-fold increases in the pheomelanin to eumelanin ratio, and a tan-yellow color in pelletted cells. Moreover, ASIP-treated cells showed reduced proliferation and a melanoblast-like appearance, seen also in melanocyte lines from yellow (A(y)/a and Mc1r(e)/ Mc1r(e)) mice. However ASIP-YY, a C-terminal fragment of ASIP, induced neither biological nor pigmentary changes. As, like ASIP, ASIP-YY inhibited the cAMP rise induced by alphaMSH analog NDP-MSH, and reduced cAMP level without added MSH, the morphological changes and depigmentation seemed independent of cAMP signaling. Melanocytes genetically null for ASIP mediators attractin or mahogunin (Atrn(mg-3J/mg-3J) or Mgrn1(md-nc/md-nc)) also responded to both ASIP and ASIP-YY in cAMP level, while only ASIP altered their proliferation and (in part) shape. Thus, ASIP-MC1R signaling includes a cAMP-independent pathway through attractin and mahogunin, while the known cAMP-dependent component requires neither attractin nor mahogunin.

Indexed as

Agouti Signaling ProteinAnimalsCell ProliferationCells, CulturedCell ShapeCyclic AMPHair ColorMelaninsMelanocytesMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutPigmentationReceptor, Melanocortin, Type 1Signal TransductionAgouti Signaling ProteinAtrn protein, mouseCyclic AMPeumelaninMelaninsMembrane ProteinsMgrn1 protein, mousepheomelaninReceptor, Melanocortin, Type 1Ubiquitin-Protein Ligases

Identifiers

PMID19493315
PMCPMC2784899
OpenAlexW2098056264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.